On October 23, 2013, John J. Lennon resigned as a Director and President/CEO and CFO of UV Flu Technologies, Inc. and from any and all other positions with the Company. Mr. Lennon will continue to provide consulting services through his consulting company, Chamberlain Capital Partners. There are no known disagreements with the company on any matter relating to the company's operations, policies or practices.

Mr. Lennon is not a member of any committee of the Board of Directors at the time of his resignation. On October 23, 2013, the Board of Directors approved the appointment of Michael Ross as Director, President and Chief Executive Officer of the company. Prior to this appointment, Mr. Ross served as Vice President of Sales for DPG, from 2012 through October 2013, where he directed a team of manufacturing representatives throughout the United States, who are responsible for all US and its territories, as well as the Caribbean, Central and South America.

Mr. Ross also managed the distribution of retail product for Canada. Jerrold B. Leikin, MD. is a medical doctor who runs one of the only dedicated comprehensive clinical toxicology programs in the country, located in Illinois.

He is on staff at all local institutions and does bedside evaluations of all clinical toxicology issues throughout the corporation. Dr. Leikin also serves multiple other states as a consultant for other issues requiring his expertise. Dr. Leikin was chosen to serve as a director for his expertise in the medical field.

Jeremy Noonan is a Service Solutions Consultant with Cisco Systems since 2013, and has been a solutions executive, program manager, engagement manager and has held other sales position for Cisco Systems since 1999. Mr. Noonan also served as a Navy pilot. Mr. Noonan's was chosen to serve as a director due to his longstanding expertise in sales.

None of the directors are expected to be named to a committee at this time.